Hadassah On Call: New Frontiers in Medicine takes you behind the headlines with Hadassah Medical Organization doctors and specialists, patients and nurses. Listen and be amazed.
Brought to you by Hadassah, The Women's Zionist Organization of America.
We're thrilled to welcome Maayan Hoffman to our Hadassah On Call team! A savvy, insightful American-Israeli journalist, today she is running a Jerusalem-based strategic communications company. Among her clients is The Jerusalem Post, where she serves as head of conferences. Previously, she served as news editor, head of strategy and senior health analyst covering the COVID-19 pandemic.
A third-generation Hadassah member, mother and wife living in Jerusalem, Maayan has held several senior journalism positions and written about health, innovation and more for publications including The Washington Post, The American Spectator, The Hill and Roll Call.
Sep 1, 2021
In our newest episode, we're updating you on all things COVID-19 and introducing you to a medical pioneer. Prof. Dror Mevorach, director of the Rheumatology Research Center and head of one of the COVID units at Hadassah Medical Organization is at the forefront of a new experimental Israeli drug called Allocetra™. It’s helping critically ill COVID-19 patients stay alive. Hear more about the drug, the clinical trials and how Hadassah hospitals are managing the mental well being of its staff during this time.